751 results
P
I/C
l, o, w, -, l, e, v, e, l, , a, r, s, e, n, i, c, , (, A, s, ), , c, o, n, c, e, n, t, r, a, t, i, o, n, , i, n, , d, r, i, n, k, i, n, g, , w, a, t, e, r, d, r, i, n, k, i, n, g, , w, a, t, e, r, , A, s, , c, o, n, c, e, n, t, r, a, t, i, o, n, s, , l, o, w, e, r, , t, h, a, n, , t, h, e, , W, H, O, , p, r, o, v, i, s, i, o, n, a, l, , g, u, i, d, e, l, i, n, e, , v, a, l, u, e, , (, 1, 0, , µ, g, /, L, )
O
p, o, o, l, e, d, , a, s, s, o, c, i, a, t, i, o, n, , b, e, t, w, e, e, n, , t, h, e, , r, e, l, a, t, i, v, e, , r, i, s, k, , o, f, , e, a, c, h, , c, a, r, d, i, o, v, a, s, c, u, l, a, r, , d, i, s, e, a, s, e, , (, C, V, D, ), , e, n, d, p, o, i, n, t, , a, n, d, , l, o, w, -, l, e, v, e, l, , A, s, , c, o, n, c, e, n, t, r, a, t, i, o, n, , i, n, , d, r, i, n, k, i, n, g, , w, a, t, e, r
P
Hepatocellular carcinomas (HCCs), non-HCC malignancies
I/C
Contrast-enhanced ultrasound (CEUS) Liver Imaging Reporting and Data System category M (LR-M), CEUS LR-M category, Non-HCC malignancies
O
Proportion of CEUS LR-M in HCC and non-HCC malignancies, Frequency of individual CEUS LR-M imaging features
P
Uropathogenic E. coli isolates
I/C
Retrieval of Uropathogenic E. coli isolates from UTI patients, Comparison of biofilm formation and antibiotic resistance in Uropathogenic E. coli isolates
O
Pooled prevalence of biofilm formation in Uropathogenic E. coli isolates: 84.6% (95% CI: 72.7-91.9)
P
malaria patients, uninfected individuals
I/C
vitamin E, blood levels of vitamin E in malaria patients vs. uninfected individuals
O
significantly lower vitamin E levels in malaria patients
P
T1DM, T2DM
I/C
insulin degludec (IDeg), insulin glargine (IGla), insulin glargine 100 U/ml (IGla100), insulin glargine 300 U/ml (IGla300)
O
glycemic variability, fasting blood glucose (FBG), standard deviation of blood glucose for 24 h, mean of 24-h blood glucose, mean amplitude of glycemic excursion, coefficient of variation for 24 h, mean of daily differences, area under the glucose curve, M-value
P
breast cancer patients
I/C
vitamin E consumption and/or supplementation, non-consumption of total vitamin E
O
breast cancer risk, recurrence, survival, and mortality
P
Patients with Parkinson's disease (PD)
I/C
Vitamins C and E, High vitamin C intake group compared to low intake group, High vitamin E intake group compared to low intake group
O
Risk of development of PD
P
patients who received total hip arthroplasty (THA)
I/C
addition of vitamin E to highly cross-linked polyethylene liners, vitamin E-free liners (non-VE-PE)
O
all-cause revision rate, femoral head penetration, clinical function
P
patients with liver lesions
I/C
LI-RADS algorithm, original studies reporting probability of LR-M for HCC and non-HCC malignancy on MRI
O
pooled percentages of HCC and non-HCC malignancy for LR-M, sources of heterogeneity between reported results
P
Cholecystolithiasis, Choledocholithiasis
I/C
Endoscopic retrograde cholangiopancreatography (ERCP), Laparoscopic cholecystectomy, 72 h after ERCP, Within 72 h after ERCP
O
Duration of cholecystectomy, Postoperative hospitalization, Complications, Conversion rate, High sensitivity C-reactive protein at 3 days after surgery, Neutrophils in the ampulla of gallbladder specimen